Qualigen Therapeutics, Inc. QLGN
3.21 0.00 (+0.00%)
At closeNov 18, 2025, 4:00 PM EST
2.86 Day range 3.34
2.35 52-week range 3.34
- YTD
- -23.75%
- 1 year
- -11.81%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Mar 31, 2020 |
|---|---|---|---|---|---|
| -5.76M | -11.30M | -14.76M | -22.66M | -1.50M | |
| -6.26M | -13.42M | -18.64M | -17.90M | -1.79M | |
| -17.55 | -132.25 | -243.00 | -305.00 | -160.00 |
Balance sheet
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Mar 31, 2020 |
|---|---|---|---|---|---|
| 1.17M | 401.80K | 3.17M | 17.54M | 153.12K | |
| 4.69M | 2.03M | 19.08M | 22.84M | 3.72M | |
| 2.01M | 4.14M | 10.32M | 6.27M | 5.65M | |
| 2.68M | -2.10M | 7.24M | 16.56M | -1.93M |
Cash flow
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Mar 31, 2020 |
|---|---|---|---|---|---|
| -6.33M | -10.30M | -13.25M | -14.73M | 57.33K | |
| -1.91M | 4.22M | -183.76K | -141.36K | -194.48K | |
| 9.01M | -550.00K | 2.91M | 8.43M | 165.14K | |
| 772.80K | -6.64M | -10.52M | -6.44M | 28.00K |